<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855060</url>
  </required_header>
  <id_info>
    <org_study_id>01-15-08B</org_study_id>
    <nct_id>NCT02855060</nct_id>
  </id_info>
  <brief_title>Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis</brief_title>
  <acronym>PATCH</acronym>
  <official_title>Pre-hospital Advanced Therapies for Control of Hemorrhage (PATCH) - Pelvis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of pelvic binders in the ambulance&#xD;
      setting improves outcomes including mortality in patients with pelvic fractures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this prospective, randomized clinical trial is to determine whether prehospital&#xD;
      use of a commercial pelvic binder will improve morbidity and mortality in patients with&#xD;
      pelvic fractures. We hypothesize that prehospital placement of pelvic binders will reduce&#xD;
      hemorrhage and need for resuscitation and will improve overall mortality in patients with&#xD;
      pelvic fractures. In addition, we hypothesize that pelvic splinting via external compression&#xD;
      will improve patients' pain regardless of whether they have a pelvic, acetabular, or proximal&#xD;
      femur fracture.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality Rate</measure>
    <time_frame>30 day</time_frame>
    <description>Percentage of patients that experience mortality within 30 days of presentation will be compared between the two study arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores - Visual Analog Scale</measure>
    <time_frame>At time of arrival to Emergency Department</time_frame>
    <description>Pain scores at presentation to hospital will be compared between the two study arms. Range 0-10. Higher scores indicate a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Skin Complications After Pelvic Binder Application</measure>
    <time_frame>From date of randomization to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year</time_frame>
    <description>The rate of occurrence of skin complications after binder application will be documented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in Hospital</measure>
    <time_frame>From date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year</time_frame>
    <description>The total number of days the patient spent in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Blood Transfusions</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of Blood Transfusions within the first 48 hours after hospital admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Pelvic Fracture</condition>
  <arm_group>
    <arm_group_label>Pelvic Binder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Commercially available device used to stabilize the pelvis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Binder</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pelvic Binder</intervention_name>
    <arm_group_label>Pelvic Binder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Traumatic injury other than ground-level fall, and&#xD;
&#xD;
          -  Complaint of pelvic groin or hip pain, or&#xD;
&#xD;
          -  Pelvic or hip deformity, ecchymosis, or crepitus in an obtunded patient, or&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ground level fall&#xD;
&#xD;
          -  Penetrating pelvis injury without frank evidence of fracture&#xD;
&#xD;
          -  Obviously pregnant patients&#xD;
&#xD;
          -  Patients who are too small or too big for the binder&#xD;
&#xD;
          -  Priority 2 or 3 Trauma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph R Hsu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <results_first_submitted>January 7, 2020</results_first_submitted>
  <results_first_submitted_qc>July 30, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 2, 2021</results_first_posted>
  <last_update_submitted>July 30, 2021</last_update_submitted>
  <last_update_submitted_qc>July 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Joseph Hsu</investigator_full_name>
    <investigator_title>Orthopaedic Trauma Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 20, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT02855060/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pelvic Binder</title>
          <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
        </group>
        <group group_id="P2">
          <title>No Binder</title>
          <description>Standard of care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pelvic Binder</title>
          <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
        </group>
        <group group_id="B2">
          <title>No Binder</title>
          <description>Standard of care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.5" lower_limit="27.0" upper_limit="45.0"/>
                    <measurement group_id="B2" value="36.0" lower_limit="24.0" upper_limit="49.0"/>
                    <measurement group_id="B3" value="36.0" lower_limit="26.0" upper_limit="47.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="23"/>
                    <count group_id="B3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mortality Rate</title>
        <description>Percentage of patients that experience mortality within 30 days of presentation will be compared between the two study arms</description>
        <time_frame>30 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pelvic Binder</title>
            <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
          </group>
          <group group_id="O2">
            <title>No Binder</title>
            <description>Standard of care</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality Rate</title>
          <description>Percentage of patients that experience mortality within 30 days of presentation will be compared between the two study arms</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores - Visual Analog Scale</title>
        <description>Pain scores at presentation to hospital will be compared between the two study arms. Range 0-10. Higher scores indicate a worse outcome.</description>
        <time_frame>At time of arrival to Emergency Department</time_frame>
        <population>Pain scores were not documented in the Emergency Department for all patients. Only patients with scores documented were included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Pelvic Binder</title>
            <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
          </group>
          <group group_id="O2">
            <title>No Binder</title>
            <description>Standard of care</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores - Visual Analog Scale</title>
          <description>Pain scores at presentation to hospital will be compared between the two study arms. Range 0-10. Higher scores indicate a worse outcome.</description>
          <population>Pain scores were not documented in the Emergency Department for all patients. Only patients with scores documented were included in this analysis.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" lower_limit="7.5" upper_limit="10"/>
                    <measurement group_id="O2" value="10.0" lower_limit="7.0" upper_limit="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Skin Complications After Pelvic Binder Application</title>
        <description>The rate of occurrence of skin complications after binder application will be documented.</description>
        <time_frame>From date of randomization to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pelvic Binder</title>
            <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Skin Complications After Pelvic Binder Application</title>
          <description>The rate of occurrence of skin complications after binder application will be documented.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay in Hospital</title>
        <description>The total number of days the patient spent in the hospital</description>
        <time_frame>From date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pelvic Binder</title>
            <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
          </group>
          <group group_id="O2">
            <title>No Binder</title>
            <description>Standard of care</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay in Hospital</title>
          <description>The total number of days the patient spent in the hospital</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="7.5" lower_limit="2.5" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Blood Transfusions</title>
        <description>Number of Blood Transfusions within the first 48 hours after hospital admission</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pelvic Binder</title>
            <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
          </group>
          <group group_id="O2">
            <title>No Binder</title>
            <description>Standard of care</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Blood Transfusions</title>
          <description>Number of Blood Transfusions within the first 48 hours after hospital admission</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 day</time_frame>
      <desc>Medical record was reviewed for all patients after 30 days</desc>
      <group_list>
        <group group_id="E1">
          <title>Pelvic Binder</title>
          <description>Commercially available device used to stabilize the pelvis&#xD;
Pelvic Binder</description>
        </group>
        <group group_id="E2">
          <title>No Binder</title>
          <description>Standard of care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rachel Seymour</name_or_title>
      <organization>Atrium Health</organization>
      <phone>74-355-6969</phone>
      <email>rachel.seymour@atriumhealth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

